Lab
MB Clinical Laboratories Corp.
MB Clinical Laboratories Corp. was paid $1.30M by Medicaid between Jan 2018 and Dec 2024, across 62 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 15% of everything it billed.
33Billing provider infoMB CLINICAL LABORATORIES CORP.
NAGUABO, PR 00718
NAGUABO, PR 00718
33aNPI1609029651assigned 11/03/2008
33bProvider typeClinical Medical Laboratory
28Total paid$1.30M
24GClaims117,332
24DCodes billed62
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#88 of 777
Median peer was paid$278K
This provider vs. median4.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 21,090 | $176K | |
| 2019 | 17,798 | $141K | |
| 2020 | 12,993 | $134K | |
| 2021 | 14,412 | $177K | |
| 2022 | 16,524 | $231K | |
| 2023 | 16,764 | $204K | |
| 2024incomplete | 17,751 | $234K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 15% | 11,594 | 10,385 | $196K |
| 80061 | Lipid panel | 12% | 11,431 | 10,269 | $159K |
| 80053 | Comprehensive metabolic panel | 9.1% | 10,890 | 9,705 | $118K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8.0% | 2,444 | 2,155 | $104K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 6.9% | 3,451 | 3,061 | $90K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.4% | 10,829 | 9,615 | $71K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.5% | 5,860 | 5,231 | $58K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.0% | 2,170 | 1,977 | $52K |
| 84439 | 3.5% | 5,659 | 4,998 | $46K | |
| 85027 | 3.1% | 6,746 | 5,661 | $40K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.2% | 599 | 542 | $29K |
| 82274 | 2.1% | 1,918 | 1,730 | $27K |
50 more codes
| 87276 | 2.0% | 2,323 | $26K | |
| 87275 | 1.8% | 2,322 | $24K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.8% | 2,730 | $23K |
| 86701 | 1.6% | 2,654 | $21K | |
| 81001 | 1.6% | 7,587 | $21K | |
| 82043 | 1.3% | 3,350 | $17K | |
| 86738 | 1.3% | 1,384 | $17K | |
| 81000 | 1.3% | 6,032 | $17K | |
| 82045 | 1.2% | 481 | $16K | |
| 87490 | 1.1% | 743 | $14K | |
| 87590 | 1.1% | 730 | $14K | |
| 84153 | <1% | 730 | $12K | |
| 87088 | <1% | 1,476 | $12K | |
| 84436 | <1% | 1,651 | $10K | |
| 84479 | <1% | 1,742 | $9K | |
| 86592 | <1% | 2,038 | $8K | |
| 82951 | <1% | 652 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 788 | $6K |
| 82607 | <1% | 353 | $5K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 122 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 110 | $4K |
| 87177 | <1% | 517 | $2K | |
| 86803 | <1% | 175 | $2K | |
| 82952 | <1% | 407 | $2K | |
| 86328 | <1% | 107 | $2K | |
| 85651 | <1% | 598 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 35 | $2K |
| 80074 | <1% | 42 | $1K | |
| 82570 | <1% | 269 | $1K | |
| 86038 | <1% | 109 | $1K | |
| 84703 | <1% | 168 | $1K | |
| 87076 | <1% | 144 | $943.87 | |
| 85730 | <1% | 178 | $919.37 | |
| 87390 | <1% | 54 | $847.16 | |
| 84550 | <1% | 231 | $822.14 | |
| 80050 | General health panel | <1% | 69 | $677.33 |
| 85610 | <1% | 170 | $604.29 | |
| 82950 | <1% | 106 | $505.73 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 66 | $402.20 |
| 87899 | <1% | 26 | $326.02 | |
| 83655 | <1% | 29 | $319.86 | |
| 86140 | <1% | 64 | $275.59 | |
| 83001 | <1% | 14 | $239.08 | |
| 86696 | <1% | 12 | $198.93 | |
| 82947 | <1% | 46 | $166.77 | |
| 86694 | <1% | 12 | $155.94 | |
| 84460 | <1% | 30 | $140.06 | |
| 84450 | <1% | 30 | $136.81 | |
| 84160 | <1% | 18 | $91.60 | |
| 86430 | <1% | 17 | $62.20 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBELTRAN, MYRNA (VICE PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Myrna Liz Beltran | Naguabo, PR | $3.00M |
| Myrna Liz Beltran | Carolina, PR | $222K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.